Shattuck Labs Aktie
WKN DE: A2QD61 / ISIN: US82024L1035
|
06.01.2026 04:30:09
|
Why Shattuck Labs Stock Soared in December
A recommendation upgrade from an analyst at the beginning of December set the tone for Shattuck Labs (NASDAQ: STTK) stock in 2025's final month. The clinical-stage biotech's share price rose by almost 74% as a result.The person responsible for that influential move was H.C. Wainwright's Joseph Pantginis, who on Dec. 1 shifted his recommendation on Shattuck to buy from his previous neutral. He set his new price target at $6 per share, which at the time was nearly three times the stock's level. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Shattuck Labs Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Shattuck Labs Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
| Shattuck Labs Inc Registered Shs | 4,32 | 8,54% |
|